Molecular subtype approximated by quantitative estrogen receptor, progesterone receptor and Her2 can predict the prognosis of breast cancer.

Xiao Song Chen, Chuan Dong, Jia Wu, Wen Tao Yang, Hong Lu, Jiong Wu, Jin Lu, Zhi Min Shao, Zhen Shen, Kun Wei Shen

PubMed · 2010 · 37 citations · 23 references

Abstract

Breast cancer subtypes based on quantitative ER, PR, and Her2 may be predictive of prognosis. Patients whose tumors were not HR+/Her2- had a worse outcome in our study.

References

23